Can SLED Cause Schistocytes to Appear?
No, slow low-efficiency dialysis (SLED) itself does not directly cause schistocytes to appear on peripheral blood smears. Schistocytes are fragmented red blood cells that result from mechanical shearing or microangiopathic processes, not from the dialysis modality itself.
Understanding the Mechanism
SLED is a hybrid dialysis technique that uses:
- Extended treatment duration (8-12 hours)
- Reduced blood flow rates (typically 200 ml/min)
- Lower dialysate flow rates (300-350 ml/min)
- Standard hemodialysis equipment 1, 2, 3
The key distinction: Unlike extracorporeal membrane oxygenation (ECMO) or mechanical circulatory support devices that can cause mechanical hemolysis and schistocyte formation through high shear stress 4, SLED operates at relatively low flow rates that minimize mechanical trauma to red blood cells.
When Schistocytes Indicate Serious Pathology
If you observe schistocytes in a patient receiving SLED, you must immediately investigate for thrombotic microangiopathy (TMA), not attribute them to the dialysis modality:
Diagnostic Threshold
- >1% schistocytes is a robust morphological indicator for TMA in adults 5
- Schistocytes are a critical diagnostic finding for conditions like TTP, HUS, and other microangiopathic hemolytic anemias 6, 7
Essential Workup When Schistocytes Are Present
You must immediately obtain 6:
- ADAMTS13 activity level (severely deficient <10 IU/dL indicates TTP)
- LDH, haptoglobin, reticulocyte count
- Direct antiglobulin test (Coombs test - should be negative in TMA)
- Platelet count (typically severely decreased)
- Peripheral smear confirmation by counting ≥1,000 RBCs 5
- Stool for Shiga toxin/E. coli O157 (for HUS)
Critical Clinical Context
The presence of schistocytes with:
- Thrombocytopenia
- Hemolytic anemia (elevated LDH, low haptoglobin)
- Renal insufficiency
This triad constitutes a medical emergency requiring immediate hematology consultation 6, 7. Delay in recognition increases mortality and morbidity.
Common Pitfall to Avoid
Do not assume schistocytes are "expected" or "normal" in dialysis patients. While SLED is gentler hemodynamically than intermittent hemodialysis 3, 8, it does not cause the mechanical shearing forces necessary to produce schistocytes. Their presence indicates:
- Underlying TMA (TTP, HUS, drug-induced)
- Severe sepsis with DIC
- Malignant hypertension
- Mechanical heart valve dysfunction
- Other microangiopathic processes
None of these are caused by SLED itself.
Technical Note on Schistocyte Identification
When evaluating for schistocytes 5:
- Count at least 1,000 RBCs in optimal smear areas
- Use ICSH standardized morphological criteria
- Report as a percentage
- Interobserver variability is reduced with strict adherence to guidelines
Bottom line: If schistocytes appear in a patient on SLED, investigate aggressively for life-threatening TMA or other serious pathology—do not attribute them to the dialysis modality 6, 7.